Jubazi


Active Ingredient

Azithromycin

Strength

250/500 mg

Pack Size

6/3 tablets

Scheduling Status

S4

Reg No.

45/20.1.1/0969, 0970

Indications

Lower respiratory tract infections including bronchitis and pneumonia, uncomplicated skin and soft tissue infections & sinusitis, alternative first line therapy for pharyngitis or tonsillitis, uncomplicated genital infections due to Chlamydia trachomatis in STDs. Children: Treatment of bacterial exacerbations of pharyngitis, tonsillitis and otitis in children 45kg.

For full prescribing information, please refer to the package insert approved by the Medicines Regulation Authority.